PEDIATRICS Vol. 98 No. 4 October 1996, pp. 730-734
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parravicini, E.
Right arrow Articles by Stark, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parravicini, E.
Right arrow Articles by Stark, R. I.

Iodine, Thyroid Function, and Very Low Birth Weight Infants

Elvira Parravicini MD1, Corinna Fontana MD2, Giuseppe L. Paterlini MD2, Paolo Tagliabue MD2, Franco Rovelli MD2, Kenneth Leung MS3, and Raymond I. Stark MD3

1 Division of Neonatal Pathology and Laboratory of Radioimmunology, Ospedale S. Gerardo dei Tintori, Monza, Milan, Italy; Department of Pediatrics, Division of Perinatology, College of Physicians and Surgeons, Columbia University, New York, New York
2 Division of Neonatal Pathology and Laboratory of Radioimmunology, Ospedale S. Gerardo dei Tintori, Monza, Milan, Italy
3 Department of Pediatrics, Division of Perinatology, College of Physicians and Surgeons, Columbia University, New York, New York

Objective. Research was undertaken to test two hypotheses. First, during the early neonatal period, thyroid function of very low birth weight (VLBW) infants is suppressed by exposure to iodine-containing antiseptic solutions and/or iodized contrast media. Second, this suppression is more pronounced in small for gestational age (SGA) infants.

Methods. Urinary iodine concentration and thyroid function measurements were obtained prospectively from 44 VLBW infants with gestational ages at birth of 30 ± 2.3 weeks and weights of 1223 ± 231 g. Eleven of these infants were SGA. The infants were grouped according to iodine exposure: 18 infants had no increased exposure and served as control infants; 9 infants were exposed to an iodine-containing antiseptic (povidone iodine); 12 infants were exposed to an iodized contrast medium (iopamidol); and 5 infants were exposed to both agents. Urinary iodine and serum free triiodothyronine, free thyroxine, and thyrotropin were measured on days 1, 7, 14, 21, and 28 of life.

Results. During the period of maximum exposure (days 1 to 7), the concentration of iodine in the urine of study infants was 2 to 4 orders of magnitude greater than that in the urine of control infants (123 ± 141 µg/L). During the subsequent 3 weeks, levels of urinary iodine in study infants returned to levels that were not significantly different from controls. On day 7 of life, iodine-exposed infants had a significantly higher mean thyrotropin level than control infants, whereas on day 28, free triiodothyronine and thyroxine levels were lower. Of the 26 iodine-exposed infants, 6 had transient hyperthyrotropinemia and 2 had transient hypothyroidism. When exposed to iodine, SGA infants had more labile thyroid function than normally grown iodine-exposed or control infants. These SGA infants had significantly lower levels of thyroid hormones in umbilical cord blood, increased production of thyroid hormones on day 14 of life, and lower levels again at 1 month.

Conclusion. In VLBW infants, the use of iodine-containing antiseptic solutions and iodized contrast media results in massive uptake of iodine that is associated with alterations in thyroid function. It is reasonable to suggest that, whenever possible, iodized products should be avoided in VLBW infants, because their routine use results in exposure to excessive loads of iodine, which can be associated with hyperthyrotropinemia and hypothyroidism.

Submitted on September 15, 1995
Accepted on December 12, 1995




This article has been cited by other articles:


Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
D E Odd, B Page, M R Battin, and J E Harding
Does radio-opaque contrast improve radiographic localisation of percutaneous central venous lines?
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2004; 89(1): F41 - F43.
[Abstract] [Full Text] [PDF]

Home page
 Evid. Based Nurs.Home page
J. Van Esch
Chlorhexidine reduced catheter tip colonisation more than 10% povidone-iodine in critically ill neonates
Evid. Based Nurs., July 1, 2002; 5(3): 73 - 73.
[Full Text] [PDF]

Home page
 PediatricsHome page
J. S. Garland, C. P. Alex, C. D. Mueller, D. Otten, C. Shivpuri, M. C. Harris, M. Naples, J. Pellegrini, R. K. Buck, T. L. McAuliffe, et al.
A Randomized Trial Comparing Povidone-Iodine to a Chlorhexidine Gluconate-Impregnated Dressing for Prevention of Central Venous Catheter Infections in Neonates
Pediatrics, June 1, 2001; 107(6): 1431 - 1436.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
J Dembinski, V Arpe, M Kroll, G Hieronimi, and P Bartmann
Thyroid function in very low birthweight infants after intravenous administration of the iodinated contrast medium iopromide
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2000; 82(3): 215F - 217.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
G Weber, M C Vigone, A Rapa, G Bona, and G Chiumello
Neonatal transient hypothyroidism: aetiological study
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 1998; 79(1): 70F - 72.
[Abstract] [Full Text]

Home page
 PediatricsHome page
M. E. Avery
Neonatology
Pediatrics, July 1, 1998; 102(1): 270 - 271.
[Full Text]